Priority setting during the COVID-19 pandemic: going beyond vaccines

Research output: Contribution to journalComment/debatepeer-review


  • Beverley Essue
  • Elysee Nouvet
  • Lars Sandman
  • Donya Razavi
  • Mariam Noorulhuda
  • Susan Goold
  • Marion Danis
  • Godfrey Biemba
  • Julia Abelson
  • Lydia Kapiriri

Colleges, School and Institutes


Development of vaccines is a major breakthrough in the fight against the SARS-CoV-2 virus.

Much attention has been paid to how to prioritise between patient groups for vaccination and how to ensure equity, especially in low-income countries, but there are other important decisions that need to be made.

These decisions include: (a) choosing between the various vaccines that will become available, (b) continuing to invest in other aspects of the COVID-19 response and (c) balancing the COVID-19 response with the need to invest in other healthcare that has suffered during the pandemic.

Although these decisions are inherently difficult, principles of good priority setting can be helpful; these principles include: evidence-based and transparent decision-making, participation of stakeholders and a focus on the implementation of decisions.


Original languageEnglish
Article numbere004686
Number of pages4
JournalBMJ Global Health
Issue number1
Early online date18 Jan 2021
Publication statusPublished - Jan 2021


  • COVID-19 Vaccines/administration & dosage, COVID-19/epidemiology, Cost-Benefit Analysis, Decision Making, Health Priorities, Humans, Pandemics/prevention & control, SARS-CoV-2

Sustainable Development Goals